U.S. Markets closed

Can Novavax (NVAX) Continue to Rise?

Zacks Equity Research

Novavax, Inc. (NVAX) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because NVAX is now in overbought territory with an RSI value of 80.4. Furthermore,  Novavax currently has a Zacks Rank #4 (Sell), suggesting that investors may want to consider exiting this stock now before it falls back to Earth.

NOVAVAX INC (NVAX): Free Stock Analysis Report

Zacks Investment Research